tradingkey.logo

Cardinal Health Inc

CAH
View Detailed Chart
214.880USD
+3.650+1.73%
Close 01/30, 16:00ETQuotes delayed by 15 min
51.14BMarket Cap
32.28P/E TTM

Cardinal Health Inc

214.880
+3.650+1.73%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.73%

5 Days

+3.14%

1 Month

+4.56%

6 Months

+38.44%

Year to Date

+4.56%

1 Year

+73.77%

View Detailed Chart

TradingKey Stock Score of Cardinal Health Inc

Currency: USD Updated: 2026-01-30

Key Insights

Cardinal Health Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 7 out of 159 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 232.46.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Cardinal Health Inc's Score

Industry at a Glance

Industry Ranking
7 / 159
Overall Ranking
26 / 4536
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive+

Cardinal Health Inc Highlights

StrengthsRisks
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 222.58B.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 222.58B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 31.52%.
Fairly Valued
The company’s latest PE is 32.28, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 215.79M shares, decreasing 0.05% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 3.33K shares of this stock.

Analyst Rating

Based on 18 analysts
Buy
Current Rating
233.771
Target Price
+10.67%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Cardinal Health Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Cardinal Health Inc Info

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
Ticker SymbolCAH
CompanyCardinal Health Inc
CEOWeitzman (Deborah L)
Websitehttps://www.cardinalhealth.com/en.html
KeyAI